We are creating some awesome events for you. Kindly bear with us.

HKSTP Co-Launches Co-Incubation Programme to Drive Biomedical Tech Development

Image Credits: HKSTP, Press Release

Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering with a global research-driven biopharmaceutical leader in a strategic co-incubation collaboration to promote and nurture start-ups in research and development for infectious diseases and immunology.

HKSTP is dedicated to collaborating with sector leaders in building the strongest I&T eco-system to help start-ups via business development, mentorship and investment initiatives. In the last five years, the number of biotech companies at HKSTP has tripled from 50 to over 150, which has also synched with the Government’s strategic focus on biomedical technology with an allocation of HK$10 billion to develop life and health technology as a key future growth sector for Hong Kong.

This partnership between HKSTP and the biopharmaceutical leader marks a key milestone to drive Hong Kong’s biomedical technology development. Both local and global qualified start-ups in infectious diseases and immunology can apply to the incubation programme to access the full capabilities of the HKSTP ecosystem and the biopharmaceutical leader’s extensive biotech funding network.

Incubatees can access one-on-one coaching and assessment to track key research milestones while receiving expert guidance from HKSTP on commercialisation, manufacturing, scaling-up and marketing strategy to ensure successful innovation, plus vital funding opportunities and investment insight from BI.

The CEO of HKSTP stated that Hong Kong is now Asia’s largest and the world’s second-largest fundraising hub for biotech. As HKSTP enters its second decade of propelling success and innovation, its mission is to drive the growth of biotech to another level with world-class leaders like the biopharmaceutical leader. The aim is to maximise the GBA growth opportunities for high-potential tech talents and early-stage start-ups to ensure the region emerges as a global I&T powerhouse.

The Head of the Institute for Translational Research of HKSTP stated that the partnership provides early-stage start-ups and promising university spinoffs with vital support at the most critical stage of their long and challenging biotech innovation journey.

Incubatees will have access to HKSTP’s Incu-Bio Programme, with total incubatees doubling up in the last five years. The start-ups can also access funding support of up to HK$6 million, with financial subsidies and upfront grants to cover regulatory activities such as clinical trials.

Meanwhile, the Global Head of the biopharmaceutical leader stated that the jointly initiated co-incubation program will enable the company to identify more breakthrough technologies in the early stage of development. With the funding and infrastructure support offered by the two parties’ expertise and experiences in the successful development of breakthrough medications for patients, the start-ups will be fostered and the gap between science and industry can be bridged to enable the local ecosystem.

The President & CEO of the biopharmaceutical leader’s China branch stated that the innovation competency of biopharmaceuticals in Asia is rising quickly. To grab the opportunities in this market, the company has set up the External Innovation Hub in China. He added that this presents a great opportunity to partner with HKSTP to develop the local ecosystem, and further enhance China’s dual-circulation scheme.

Programme incubatees will also benefit from HKSTP’s rapidly-growing biotech R&D capabilities including the HKSTP Institute for Translational Research (ITR), enabling biomedical start-ups to turn their innovative biomedical technologies into life-changing impact on patients and society. Also available to start-ups is HKSTP’s Incu-Bio program providing dedicated biotech mentorship, business matching, entrepreneur-in-residence, and access to R&D facilities and the Science Parks’ diverse talent pool.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.

Send this to a friend